Form 483

American Chinese Natural Herbs, Inc. Form 483, 2019-05-28

FDA issued a Form 483 to American Chinese Natural Herbs, Inc. on 2019-05-28 with 15 public-safe observations.

483· Form 483 issuedFoods & Cosmetics15 observations

American Chinese Natural Herbs, Inc. · Garland, United States · Issued May 28, 2019

Overview

  • 15 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 May 2019
21 CFR 111.70(d)

Specifications - labels, packaging

Cited by Shannon A Lowe

28 May 2019
21 CFR 111.75(a)(2)(ii)(A)

Component - qualify supplier

Cited by Shannon A Lowe

28 May 2019
21 CFR 111.103

Written procedures - quality control operations

Cited by Shannon A Lowe

28 May 2019
21 CFR 111.205(a)

Master manufacturing record - unique formulation

Cited by Shannon A Lowe

28 May 2019
21 CFR 111.403

Written procedures - labeling operations

Cited by Shannon A Lowe

Inspected site

ACAmerican Chinese Natural Herbs, Inc.Garland, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.205(a)Cited across public-safe Form 483 observations2x
21 CFR 111.403Cited across public-safe Form 483 observations2x
21 CFR 111.70(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.70(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.70(d)Cited across public-safe Form 483 observations2x
21 CFR 111.70(e)Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations2x
21 CFR 111.103Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 15 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere